PowerPoint プレゼンテーション
|
|
|
- ありおき あいしま
- 7 years ago
- Views:
Transcription
1
2
3 1.
4
5
6
7
8
9
10 徘
11
12
13 梗
14
15
16
17
18 徘
19 2.
20
21
22
23 3 1 1 a b c 2 a b c a : b : c : a b c a: b: c:
24
25
26
27
28 seahorse ()Hippocampus coronatus
29
30
31
32 3.
33
34
35 ( ) McGeer P.L.
36
37
38
39
40 HCI
41
42
43
44 v.s.
45
46 徘
47
48 4.
49
50
51
52
53 5.
54 IDO Coppen A., Br. J. of Psychiatry 113:
55 (Dowlati et al. Biol Psychiatry 2010: 67: )
56 / IL-6, TNF-, and Il-1 CRP C(IFN- (Dantzer et al., 2008) (Besedovsky et al., 2000, Golden et al., 2005)
57 IDO (Muller and Schwarz, 2007)
58 (Serafeim et al, 2003; Blood) Amit et al, 2009; Euro Neurpsychophamacol) (Taler et al, 2008; Int Immunophamacol)
59 ) (TNF-) (Horikawa et al, 2010)
60 (Ownby et al, 2006; Leonard, 2007)
61 (mild cognitive impairment) (Mowla et al., 2007; Mosselo et al., 2008) (Kessing et al., 2009)
62
63 !?
64
65
66
67
6 1873 6 6 6 2
140 2012 12 12 140 140 140 140 140 1 6 1873 6 6 6 2 3 4 6 6 19 10 39 5 140 7 262 24 6 50 140 7 13 =1880 8 40 9 108 31 7 1904 20 140 30 10 39 =1906 3 =1914 11 6 12 20 1945.3.10 16 1941 71 13 B29 10 14 14
JA2008
A1 1 10 vs 3 2 1 3 2 0 3 2 10 2 0 0 2 1 0 3 A2 3 11 vs 0 4 4 0 0 0 0 0 3 6 0 1 4 x 11 A3 5 4 vs 5 6 5 1 0 0 3 0 4 6 0 0 1 0 4 5 A4 7 11 vs 2 8 8 2 0 0 0 0 2 7 2 7 0 2 x 11 A5 9 5 vs 3 10 9 4 0 1 0 0 5
2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1
産衛誌57-4たより.indb
A89 26 7 1 9 4 33 1 87 A90 24 A91 23 ACOH2014 A92 4 1 2 3 4 5 6 7 A93 A94 A95 A96 A97 A98 A99 A100 A101 27 8 1 9 A102 4 33 A103 A104 26 3 140 27 1 A105 27 A106 A107 A108 A109 A110 A111 A112 A113 et al
3 4 6 7 8 9 10 12 14 2 3
3 4 6 7 8 9 10 12 14 2 3 POINT 4 5 3053 1323 4 7 6 1 1 4 7 Yamada N. et al : Int J Cardiol. 98, 409-411, 2005 6 7 POINT 0 20 40 60 80 100 60 80 Ota M. et al: Heart Vessels. 17, 7-11,2002 40 60 20 50 15
- 25 - - 26 - 徘 - 27 - - 28 - - 29 - - 30 - - 31 - - 32 - - 33 - - 34 - - 35 - - 36 - - 37 - - 38 - - 39 - - 40 - - 41 - 茨 - 42 - - 43 - - 44 - - 45 - - 46 - - 47 - - 48 - - 49 - - 50 - 牌 - 51 - 牌 - 52
商標審査基準について
- 1 - - 2 - - 3 - - 4 - - 5 - () 9 14 58 19446 ) - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - 16 6 8 15()265 LEONARD KAMHOUT - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 -
02
54 163116831 02 1 168 54 158 53 162 53 148 52 152 52 10,000 0 40,000 30,000 20,000 50,000 70,000 60,000 1,000 500 1,500 2,000 0 2,500 3,000 4,000 3,500 4,500 168 54 158 53 162 53 148 52 152 52 03 52148
00 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0..0..........0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0... 0...... 0... 0 0 0 0 0 0..0 0... 0 0 0 0 0.0.....0.
Microsoft Word - 倫理 第40,43,45,46講 テキスト.docx
6 538 ( 552 ) (1) () (2) () ( )( ) 1 vs () (1) (2) () () () ) ()() (3) () ( () 2 () () () ()( ) () (7) (8) () 3 4 5 abc b c 6 a (a) b b ()() 7 c (c) ()() 8 9 10 () 1 ()()() 2 () 3 1 1052 1051 () 1053 11
untitled
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Int J Radiat Oncol Biol Phys 49 Cancer 101 Int J Radiat Oncol Biol Phys 60 Chest 124 Int J Radiat Oncol Biol Phys 56 Int J Radiat Oncol Biol Phys 49 Chest 124 Int J
untitled
NO.39 NO.39 ---------------------------------------------------------------------- http://clickanketo.com/cgi-bin/a.cgi?q00006480a20-1- -2- -3- http://clickanketo.com/cgi-bin/a.cgi?q00006577a01 http://clickanketo.com/cgi-bin/a.cgi?q00006577a72
2.2 (1967) (1997,2003) 2.2 ( ) 11
( ) 2.1 10 2.2 (1967) (1997,2003) 2.2 ( ) 11 12 ( ) 90150 (684) (887) (1099) (1361) (1605) (1707) (1854) 21(1946) 8 2.3 (1854) 13 (1997) (1854.12.23) (M8.4) (24 ) (M8.4) 70,000 3000 ( ) 7 2 3 3 (,1997)
Proposal Template
74 2 3 33.5 33.5 13.0 13.0 16.5 16.5 11.0 11.0 10.5 10.5 10.5 10.5 0.5 0.5 3.5 3.5 1.0 1.0 35.0 (180n) 90 65.0 40.0 (20n) 10 60.0 4 5 20 20 24 24 0 25 25 29 29 20.0 20.0 30 30 34 34 20.0 20.0 35 35 39
日本目録規則1987年版改訂2版第2章図書改定案
2.0.1 2.0.2 2.0.3 2.0.4 2.0.5 2.0.6 2.1.1 2.1.2 2.1.3 2.1.4 2.1.5 2.2.1 2.2.2 2.2.3 2.2.4 2.4.1 2.4.2 2.4.3 2.4.4 2.5.1 2.5.2 2.5.3 2.5.4 2.6.1 2.6.2 2.6.3 2.6.4 2.6.5 ISSN 2.6.6 2.6.7 2.7.1 2.7.2 2.7.3
untitled
2012 http://nomichi-sakura.cocolog-nifty.com/blog/ 2012-1 - 2012-2 - 2012-3 - 2012-4 - 2012-5 - 2012-6 - 2012-7 - 2012-8 - 2012-9 - 2012 = = http://www.facebook.com/#!/organicbreeze08 Facebook... 11 4
432..
et al., et al., et al., år är ön Nature Rep. int. Whal. Commn Mar. Mamm. Sci ICES Journal of Marine Science år år önlobodon carcinophaguscanadian Journal of Fisheries and Aquatic Sciences Rep. int.
untitled
26 9 201491 PL PL PL 1 1 2 3 4 1 1 2 3 4 1,000 10 501003 7 5 6 2 10 1 1 10 2 2 1,000 1,000 50100 50100 50100 50 100 5 6 3 4 3 2 1 10 1100 11,000 1 5001,000 150 1,000 1,000 1,000 90 15001,000 15,000 15,000
医薬品リスク管理計画書
2.5 mg 3.75 mg 5 mg 20mg RMP 2.5 mg 3.75 mg 5 mg 20mg 87339 28 6 1.1 4 8 10 5 8 10 5 TTP 9 梗 6 TIA 11 6 1.2 11 CABG 12 12 13 13 15 2.5mg 15 2. 16 3. 16 4. 19 19 19 18 RMP 28 6 3 5 1 27 8 25 26 3 24 87339
表1.eps
Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol
MI( MI() 100% 100% 75% 75% 33% 75% 60% 40% 25% 60% 1 2 3 4 5 6 7 8 9 () 12 () () () !! 1. 2. 3. 1. 2. () () () 3-5% ex. ex. 11 ex. () ex. ex. : ex. : (insula) () () ( 2009 ) () ( ) YES! ()
3) Balas. C. Michele, Happ. B. Beth, Yang. Wei et al: Outcomes associated with delirium in older patients in surgical ICUs, Chest, vol.135 (1), 18-25, 2009 4) Ban Thomas; Chronic disease and depression
22
2015 75 7074 6569 2064 26470 21 22 4,060 1,330 23 24 15,000 80 24,600 15,000 15,000 24,600 15,000 24,600 15,000 24,600 37,200 145 520 383 44,400 25 26 280 160280 280 346 160 80 160 37,200 24,600 15,000
Various function and toxicity of iron Key words 1) Hentze, M. W. et al: Cell, 117, 285-297 (2004) 2) Ganz, T.: Blood, 102, 783-788 (2003) 3) Nemeth, E. et al.: Science, 306, 2090-2093 (2004) 4) Hentze,
/41
3 1 3 2 7 2-1 7 3 8 3-1 7S 8 3-2 9 3-2-1 9 3-2-2 10 3-2-3 10 3-2-4 10 3-2-5 11 3-2-6 11 3-2-7 12 4 13 4-1 13 4-2 13 4-2-1 13 4-2-2 13 4-3 14 4-3-1 5 14 4-3-2 XY 15 4-3-3 16 4-4 17 4-4-1 17 4-4-2 & 17 4-4-3
がん患者の終末期ケアにおける通所リハビリテーションの役割 介護保険によるがん終末期ケアの可能性
2 3 3 6 7 49 53 13 61 22 27 65 68 34 47 71 73 4 5 7 6 8 9 10 11 12 13 14 15 44 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
90 86.3 85 80 79.55 12.68 75 9.13 70.42 73.62 70 65 60 2222 22 Deadly Quartet 梗 梗 腿 Age Related Cognitive Decline Youth Middle age Elderly Source: Neurol. Aging 8, 501-510, 1987 * * DHA COOH Toxic
2 Gy-IGF'5 ng/ml
2 Gy-IGF'5 ng/ml CONCLUSION : The decrease in the number of differentiated cells and reduction in myotube formation induced by X'ray radiation of 2 Gy were inhibited by IGF-1. The X-ray irradiation at
1. 2. 1 1 2 1 1 2 2 3. 3 3 4 5 4 5 6 6 41 21 16 20 14 79 1. 5 1 2. 1 1 1 1 2 2 3 3 3. 4. 5. 6. 1. 2. 3. 4. 1 5. 6. 26 108 1. 2. 3. 4. 1. 1 Anti-inflammatory IL-6 IL-10 TNF-R IL-1ra 2. 1 Blood sample
2
C o r n e l i u s The Science of E m o t i o n I z a r d The Psychology of Emotions Rusalova et al. Schwartz et al E M G 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 The science of emotion The psychology
NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml
NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008
スライド 1
Randomized Trees CV 1: [Lepetit et al., 2006] CV 2: [Shotton et al., 2008] CV 3: [Amit & Geman, 1997] [Moosmann et al., 2006] [ et al., 2010] CVへの応用例4: TomokazuMitsui パーツベースの人検出 [三井 et al., 2011] 人の領域をパーツに分割し
untitled
NPO Topics Topics 5 74 2008.12.19 2008.12.19 2008.12.19 2008.12.19 2008.12.19 21.3% 2007/6/1 22.1% 2008/9/15 3.9 2.0 2000-2025 51.9% 2006 65 65 60 70% 80% 16.6% 20.6 aging O 2 ml/kg/min(10
PowerPoint プレゼンテーション
* ** 117,320 70,293 109,140 49,830 93,402 45,744 60,986 31,875 47,318 28,829 45,367 18,186 29,025 12,838 27,822 11,970 20,734 10,823 19,994 10,336 * 2007 ** 2011 65% 25% 9 DNA P53, ATM G1 S G2 G1 M 1
11新里論文.indd
70 Dementia Japan 27 : 70-80, 2013 56 29 41 70 80.7±7.1 53% 70 HDS - R 14.3±6.4 80% Kazuhiro Niizato 1), Gen Ohi 2) 1) 156-0057 2-1 - 1 Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital 2-1
2014 26 10 18 9301000 925 927 930 31 33 36 39 42 45 48 50 53 14 20 11 8 13 3 14 12 34 22 20 8 0 49 12 12 28 23 12 22 11 7 6 26 2 4 27 5 6 2 8 10 0 45 17 1 12 10 0 2 19 12 8 10 6 6 10 18 4
超高齢社会における共生を考える健康長寿の要因の探求 40 神出 楽木 健康長寿の要因の探求 41 未来共生学第 4 号 論文 高齢者疫学研究からの知見 Reich et al i, ii 神出計 ii 楽木宏実 大阪大学大学院医学系研究科 i 保健学専攻総合ヘルスプロモーション科学講座
Title 健康長寿の要因の探求 : 高齢者疫学研究からの知見 Author(s) 神出, 計 ; 楽木, 宏美 Citation 未来共生学. 4 P.40-P.50 Issue Date 2017-03 Text Version publisher URL https://doi.org/10.18910/60707 DOI 10.18910/60707 rights 超高齢社会における共生を考える健康長寿の要因の探求
2 3 A B 2 NPO
13 30 13 1 (1) (9) 9 1 2 3 A B 2 NPO 3 3 22 22 4 2 22 22 5 6 3 3 3 22 3 22 4 4-1 6 WG 6 3 7 8 7 7 11 4-5 3 3 2 1 4 2 Yes No 100 1 22 9 22 3 22 22 3 3 2 4-6 1 5 22 72 1 2 72 72 3 72 72 10 72 72 NPO 72 4-6
1
1 2 9 3 4 5 6 7 2 8 9 http://t.pia.jp/ Point Point TOP 10 11 http://apps.microsoft.com/windows/ja-jp/app/49b9d8c8-278d-4ebe-b320-1d81ad07ff36 http://s.pia.jp/pia/ 12 http://t2.pia.jp/info/api.html 13 http://t2.pia.jp/feature/music/musiccomplex/index.html
Systematic Review of Psychological Assessment for elder clients, No. The review about Intelligence or Memory Scale for Dementia Kyoko WATANABE
Systematic Review of Psychological Assessment for elder clients, No. The review about Intelligence or Memory Scale for Dementia Kyoko WATANABE http://www.stat. go.jp. % Mini Mental State Examination MMSE
2001 11 14 19971219947 2 13 4 1 1 1 1 200 1000 1 1 00 2 3 30 100 3 5000 5 1 100 1 100 4 5 6 1 26,234 12,084 9,142 26,916 7 , 1 1 4 8 3 9 100 1895 3516870 100 10 11 W 14 15 New 16 W 11 14 21 1 W 63
学術通信111.indd
IWASAKI ACADEMIC PUBLISHER NEWS NO. 111 2015 2 5 8 11 4 7 10 13 2015.10 12 14 30 2 3 P. D.W. W.R. 4 5 2 pluralism 1 1 6 Thoma Cecero 2009 209 1 2 3 6 4 5 6 7 Psychotherapy, 46 4, 405 417. 209 77 55 55
PowerPoint プレゼンテーション
2 9 4 16 17 15 18 6 BS 5 P/L 14 13 11 10 8 7 CF 31 32 24 45 44 41 INT 40 20 43 42 47 39 38 / / 37 36 4 20,910 14,789 3,858 3,016 18.5% 20.4% 3,140 2,344 15.0% 15.9% 717 671 3.4% 4.5% 829 709 4.0% 4.8%
FERRITES March 2014 Mn-Zn EPC
March 214 Mn-Zn EPC (2/29) AV OA (3/29) RoHS EPC EPC PC47 EP Z - 1 2 AL-value Z: PC47 EP 1 PC9 EP3 2 PC95 EP7 EP9 EPC25 EPC25B EPC27 EPC3 C C 3 to +5 3 to +85 RoHSRoHS http://www.tdk.co.jp/rohs/ Cl 9ppm
hydrology.pdf
47 9 Sherman(1932) Horton 9.1 A A 9.1.1 1932 Sherman 9 48 9.1: Q Q(j) =Σ j i=0uh(j i)r e (i) (9.1) R e UH i, j t i j 10mm 9.1 (9.1) Σ L i=0uh(i) = 1 (9.2) UH(i) 1 (i =0, 1,,L 1,L) (9.3) L (L +1) t (9.1)
437“ƒ
et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer
REM Rapid Eye Movement REM Zzz Non-REM
Sleep and sleep-related disorders in the elderly 20051027 REM Rapid Eye Movement REM Zzz Non-REM 90 180 270 360 90 How old is the elderly in sleep? 40 In: Primer of Polysomnography Circadian rhythm 24
Diagnosis of Dementia: Update
10 C A 1 2 Normal SMI MCI Early Dementia B Moderate Dementia 3 Severe Dementia 4 5 D AD, VD, FTD, DLB, PDD Depression Dementia d/t GMC Modifiable risk factors and preventive factors for dementia 6-5 -
07-第4章村上英吾.indd
1990 1990 2007 2000 2007 9 3 46 1 2 1960 1 1984 60 3 1970 4 2000 2003 2009 2011 12007 2 2007 12 25 2 1 2007 10 19 1 5 2007 12 11 3 Bradshaw, J., et. al., 2008. 41982 47 2010 5 2011 2004 2004 1994 5 2009
01_表紙
2012.1.10 8 Hijicho http://hijicho.comhttp://twitter.com/hijicho/ Hijicho http://hijicho.comhttp://twitter.com/hijicho/ () () Hijicho http://hijicho.comhttp://twitter.com/hijicho/ ( ) Hijicho http://hijicho.comhttp://twitter.com/hijicho/
(1) (2) (3) (1) (2) (3) (1) (2) (3) (4) (1) (2)
(1) (2) (3) (1) (2) (3) (1) (2) (3) (4) (1) (2) (1) (2) (3) (1) (2) (3) (1) (2) (3) vs. (2) (1) 16 22 143,977 24,030 55,769 600 (2) (3) (4) (1) (2) (1) (2) 2 (3) (abuse) (1) (2) (3) (1) (2) (3)
感染症学雑誌第77巻第8号
1 2 µ Streptococcus pneumoniae µ S. pneumoniae µ S. pneumoniae pbp β β pbp1a pbp2x pbp2b pbp mefe ermb pbp pbp1a pbp2x pbp2b pbp pbp pbp pbp 2x pbp1a pbp2x pbp 2b mefe ermb pbp β pbp2x β β β µ µ pbp3 µ
族小惑星の観測（Ｄ０４０１）
? 10/14,15 -K.3T :4796, 6611 11/12,13,15-Schmidt :2508, 10285, 10320 amplitude (phase angle=0deg) [mag] 0 0.1 0.2 0.3 0.4 2508 Alupka (P=17.70 hour) 11/12-1.05m Schmidt 11/13-1.05m Schmidt 11/15-1.05m
untitled
2005 0211059 1 4 1 1 6 A) 7 2 8 3 9 4 10 5 11 2 JR 1 13 A) 16 ATS JR 2 18 3 20 2 4 22 5 24 6 25 3 1 27 A) B) C) 2 28 A) JR 28 B) 31 C) 35 3 36 41 3 JR 43 48 65 4 2005 4 25 JR JR JR JR 5 10 30 JR PR 5 CM
6 (THI) 6.1 Hiramatsu et al.; THI WECPNL WECPNL , % THI THI The Todai Health Index CMI MDI YG MMPI
6 (THI) 6.1 Hiramatsu et al.; 1997 1 1991 1992 THI 75 95 5 5 5 1,53 87.8% 12 6.2 6.3 THI THI The Todai Health Index CMI MDI YG MMPITHI CMI 12 3 YG MMPI THI 6 2 1999 6 1 THI 12 SUSY RESP 1 EYSK 1 MOUT 1
Vol.0 No. 0 図 Montreal Cognitive AssessmentMoCA orientation visuospatial attention orientation 4 visuospatial executive MMSE MoCA language language me
Parkinson 病の認知機能障害を MMSE と MoCA により評価した多施設共同研究 : 慶應 PD データベース Cognitive impairment in Parkinson s disease patients evaluated by the Montreal Cognitive Assessment and the Mini-Mental State Examination.
橡Taro11-報告書０.PDF
Research Center RC 2001 5-1- RC RC NHK -2- -3- 00/12/16 RC 01/01/07 RC 01/01/21 1 13 01/02/11 2 9 01/02/10 01/02/14 01/02/19 01/02/25 3 7 01/03/10 4 8 01/03/23 5 8 01/04/29 2001/01/07-4- -5- RC 1990 RC
Desulfitobacterium dehalogenans Desulfitobacterium sp. Y51 Desulfitobacterium Desulfitobacterium sp. Dehalococcoides Dehalococcoides Dehalococcoides e
E-mail : kfurukaw@agr.kyushu-u.ac.jp http://www.agr.kyushu-u.ac.jp/biosci-biotech/hakko Biochemical and genetic bases of chloroethene-dehalorespiring bacteria Desulfitobacterium dehalogenans Desulfitobacterium
橡'98寺尾班報告書.PDF
(OHSS) interleukin-8 (IL -8) 33 histamine prostaglandin angiotensin 8 IL-8 OHSS 1 IL-8 23 Wistar rat pregnant mare serum gonadotropin 10 unit 48 human chorionic gonadotropin(hcg) 10 unit IL-8 0.2, 2.0,
et al
et al et al Comparative Biochemistry and Physiology. Part B FOOD Style 21 et al et al et al et al J. Cetacean Res. Manage Science Rep. int. Whal. Commn Sci. Rep. Whales Res. Inst Balaenoptera bonaerensis
スライド 1
e-japan -2004 1 Integrated Healthcare Network (IHN) e-icusentara Sentara Healthcare T C I H A H I 0 5 0 3 T C I H A H I 2 10 6 1 0 1935 40 45 50 55 60 65 70 75 80 85 90 95 2000 K. Matsuoka et al.
™…{,
16:30-17:40 1-36 1-37 1-38 1-39 1-40 1-41 1-42 33 10:00-11:10 1-43 1-44 1-45 1-46 1-47 1-48 1-49 12:00-12:50 LS4 34 16:30-17:40 1-50 1-51 1-52 1-53 1-54 1-55 1-56 35 16:30-17:40 1-57 1-58 1-59 1-60 1-61
untitled
260 250 200 150 10 100 50 0 1960 1965 1970 1975 1980 1985 1985 1995 2000 2005 25% 56% 66% 60% 90 80 70 60 50 40 30 20 10 0 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 1999 1990 2003 2005 2010 500,000 70,000 100,000
進展するコーポレート・ガバナンス改革と日本企業の再生
4-1 () IR IR 1-1 Shleifer. and Vishney (1986), McConnell and Servaes(1995) (NPV) 1986 Stulz1990 Hart and Moore1995 Lang, Ofek, and Berger (1996) 1993 1- Mehran1995 Yermack(1996) Q IR 2002 12 CorporateGovernance
: : 2001227 : 2
: : 2001227 : 2 mg/100gmg/100g mg/100g 3 10/102006 12/05 2/19, 2007 Zn 63 98 4 10% 5 Ramesh et al. 2004 6 Connoly et al. 2002 A IRT 7 8 2.11mg/100g143%56% 9 10 Alaria praelonga 11 2 12 13 14 15 16 1 1
地域主権改革と東京一極集中
2011.6.18 1 2 3 4 5 6 21 北 21 7 8 21 246 9 1985 1990 1995 2000 2005 2010 401,352 396,554 393,885 386,551 375,591 369,400 252/3 1985 1990 1995 2000 2005 2010 4,581 3,928 3,739 3,912 2,943 3,064 1,912 405
untitled
20143 3 20133 (2012.4~2012.12) 20143 (2013.4~2013.12) 113 114 +1 1,005 1,021 +16 211 195 16 256 253 3 60 60 +0 72 75 +3 21 20 1 623 605 17 65 50 14 38 33 5 6.2% 5.5% 0.7% 13 144 157 20133 3 (2012.4~2012.12)
2
1 2 3 4 5 6 7 8 9 10 11 12 13 14 10mSv 15 16 17 4.46 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 3.8 2.07 2.91 1.37 2.3 1.31 1.84 1.56 1.2 1.33 2.03 0.5 1000 4000mSv 1000 4000mSv Preston et al. Radiat Res 168: 1 64,
untitled
E-mail: khatano@fms.saitama-u.ac.jp Tel & Fax: 048-858-3535 Toxin Virus Bacterium Glycolipid Glycoprotein Vero toxin (Stx1 and Stx2) Side view Bottom view H H H H N H Grobotriaosyl Ceramide (Gb 3 : Galα1-4Galβ1-4Glcβ-Cer)
28_04_斎藤正章.indd
37 2820103743,. 282010.3743 純 粋 持 株 会 社 における 経 営 管 理 上 の 課 題 1 2 ABSTR ACT...... 1 2 1 38 2 1 1 3 2 1 1 4 5 6 7 8 1 2 1 1992.269 39 1 1 1 2 9 1 2 3 123 13 2 1995.268 40,.1995 3 10, et al.1995 2 1950 2